50 Clarence Street
Suite 506 Level 5
Sydney, NSW 2000
Australia
61 2 9078 7669
https://bioxyne.com
Sector(s): Consumer Defensive
Industry: Packaged Foods
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Samuel Watson | CEO, MD & Executive Director | 215.82k | N/A | N/A |
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD | CFO & Company Secretary | 98.5k | N/A | 1953 |
Mr. Jason Hine | COO & Executive Director | 319.27k | N/A | N/A |
Ms. Rachel Qian | Financial Controller & Assistant Company Secretary | N/A | N/A | N/A |
Bioxyne Limited, a life sciences and consumer health products company, manufactures and distributes consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines in the United Kingdom, Japan, Europe, and Australia. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, vitamins, manuka honey, skin care products, and mushroom complexes. It develops various functional food products, such as ingredients; and lactobacillus fermentum VRI-003 for over-the counter gut health immune supplement products. The company also provides product research and development services, and telemedicine services. In addition, it operates BLS Clinics, a telehealth platform. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
Bioxyne Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.